Sartorius Competitors
Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
---|---|---|---|---|---|---|---|---|
AZN | AstraZeneca PLC | Outperform |
17
|
£123.32 | £165.99 | 31.97% | 16 | £190.12B |
TMO | Thermo Fisher Scientific | Outperform |
10
|
$577.93 | $591.94 | 7.28% | 1 | $218.97B |
ROG | Roche Holding | Hold |
16
|
CHF222.30 | CHF307.83 | 22.58% | 9 | CHF179.41B |
DHR | Danaher | Outperform |
10
|
$251.43 | $260.33 | 8.35% | 4 | $184.84B |
MRK | Merck KGaA | Outperform |
18
|
155.70€ | 190.06€ | 14.32% | 4 | 67.02€B |
PH | Parker-Hannifin Corp | Outperform |
10
|
$560.69 | $548.76 | 8.44% | 7 | $71.33B |
BDX | Becton Dickinson and Co | Outperform |
9
|
$235.00 | $284.47 | 18.09% | 8 | $67.51B |
A | Agilent Technologies | Outperform |
10
|
$145.14 | $138.82 | 4.04% | 10 | $41.85B |
BIIB | Biogen | Outperform |
10
|
$222.75 | $299.62 | 29.52% | 13 | $32.43B |
BAYN | Bayer | Hold |
5
|
28.69€ | 45.15€ | 4.57% | 4 | 27.97€B |
MTD | Mettler-Toledo International | Hold |
13
|
$1.29k | $1.12k | -5.38% | 0 | $27.60B |
STE | STERIS | Outperform |
13
|
$225.99 | $238.33 | 6.65% | 4 | $20.76B |
ENTG | Entegris | Outperform |
18
|
$129.38 | $116.12 | 13.62% | 11 | $19.60B |
RGEN | Repligen | Outperform |
16
|
$164.89 | $187.18 | 24.33% | 12 | $9.25B |
GETI B | Getinge AB | Outperform |
18
|
kr232.50 | kr226.10 | -1.94% | 3 | kr63.33B |
3355 | Kuriyama Holdings | Outperform |
17
|
¥1.22k | ¥0.00 | 7.41% | 0 | ¥18.46B |